Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Filipa Lynce, M.D.

Concepts (191)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Inflammatory Breast Neoplasms920241474.500 Why?
Breast Neoplasms342024210192.170 Why?
BRCA2 Protein920248051.590 Why?
BRCA1 Protein9202411581.410 Why?
Receptor, erbB-210202425571.400 Why?
Paclitaxel3202417320.990 Why?
Neoadjuvant Therapy13202428280.890 Why?
Antineoplastic Combined Chemotherapy Protocols122024117420.880 Why?
Pyrazoles2202420090.790 Why?
Nitriles220249710.750 Why?
Ovarian Neoplasms4202348780.700 Why?
Platinum120212200.670 Why?
Antineoplastic Agents92024136420.640 Why?
Ventricular Dysfunction, Left2201921180.560 Why?
Anthracyclines320202840.530 Why?
Clinical Trials, Phase I as Topic120173260.520 Why?
Neutropenia120218850.520 Why?
Camptothecin320245910.500 Why?
Immunoconjugates420249530.490 Why?
Angiotensin-Converting Enzyme Inhibitors2201915160.480 Why?
Pyrimidines2202430280.460 Why?
Central Nervous System Neoplasms120229160.460 Why?
Medically Underserved Area120152540.440 Why?
Adrenergic beta-Antagonists1201912410.430 Why?
Molecular Targeted Therapy3201928110.420 Why?
Genes, BRCA2120156010.400 Why?
Genes, BRCA1120157640.380 Why?
Vulnerable Populations120157030.340 Why?
Female4820243927050.340 Why?
Genetic Testing4202435370.330 Why?
Troponin I220176510.330 Why?
Troponin T220177800.320 Why?
Patient Selection3202142440.310 Why?
Maytansine22019860.290 Why?
Humans5820247615960.280 Why?
Urban Population1201520360.280 Why?
Cyclin-Dependent Kinase 6220223500.280 Why?
Ovariectomy220206140.260 Why?
Population Surveillance1201525980.240 Why?
Neoplasm Recurrence, Local6202492800.210 Why?
Brain Neoplasms1202490320.210 Why?
Lymphoma1201119010.200 Why?
Protein Kinase Inhibitors1201856720.190 Why?
Angiogenesis Inhibitors1201220480.190 Why?
Mutation72022300530.190 Why?
Weight Gain1201123480.190 Why?
Omeprazole120211050.180 Why?
Neoplasm Staging72023111200.180 Why?
Survivors1201123710.180 Why?
Poly(ADP-ribose) Polymerases120234260.180 Why?
Phthalazines120233830.180 Why?
Neoplasms32019221730.180 Why?
Receptors, Estrogen3202222090.170 Why?
Genetic Predisposition to Disease32024179040.160 Why?
Urogenital System12019880.160 Why?
Lisinopril12019610.160 Why?
Piperazines2202125230.160 Why?
Prognosis42023296290.160 Why?
Treatment Outcome92024646850.160 Why?
Middle Aged2220242209210.160 Why?
Cyclin-Dependent Kinase 4220225610.150 Why?
Estrogen Receptor alpha120225830.150 Why?
Germ-Line Mutation2202418580.150 Why?
Antimetabolites, Antineoplastic120216460.150 Why?
Carboplatin120217940.150 Why?
Pyridines2202128750.150 Why?
Cardiac Imaging Techniques120202670.150 Why?
Brain12024271210.140 Why?
Maximum Tolerated Dose120198830.140 Why?
Lymphedema120235250.140 Why?
Genetic Counseling220236270.140 Why?
Antibiotics, Antineoplastic120206780.130 Why?
Aged1320241693100.130 Why?
National Cancer Institute (U.S.)120172970.130 Why?
Adult1720242212100.130 Why?
District of Columbia120151590.120 Why?
Central Nervous System1202213360.120 Why?
Cell Adhesion Molecules1202116010.120 Why?
Retrospective Studies72024806470.120 Why?
Purines120186070.120 Why?
Mastectomy1202318220.120 Why?
Neoplasms, Second Primary1202210520.120 Why?
Genetic Heterogeneity120187320.120 Why?
Jews120163560.120 Why?
Aminopyridines120185730.120 Why?
DNA Copy Number Variations1202320200.110 Why?
Neoplasm Metastasis2202449150.110 Why?
Breast1202319670.110 Why?
Endometrial Neoplasms1202313660.110 Why?
Interleukin-61202432080.110 Why?
Neovascularization, Pathologic1202426450.110 Why?
Neoplastic Cells, Circulating120209460.110 Why?
RNA1202327250.110 Why?
Benzimidazoles120188580.110 Why?
Estrogens1201915220.100 Why?
Drug Resistance, Neoplasm2202453050.100 Why?
Time Factors52021399690.100 Why?
Radiation Injuries1201911890.090 Why?
Chemotherapy, Adjuvant4202335140.090 Why?
Obesity22023129470.090 Why?
Tumor Microenvironment1202438780.090 Why?
Disease-Free Survival3202168150.090 Why?
Carrier Proteins1202449370.090 Why?
Aged, 80 and over62024589840.090 Why?
Ventricular Function, Left3202138790.090 Why?
Germ Cells220246340.080 Why?
Cytokines1202473960.080 Why?
Risk Reduction Behavior1201511120.080 Why?
Hippocratic Oath12008160.080 Why?
Young Adult62020592600.080 Why?
Neoplasm, Residual2202410080.070 Why?
Dose-Response Relationship, Drug12019107660.070 Why?
Heart Diseases1202027810.070 Why?
DNA Repair1201620460.070 Why?
Pilot Projects1201986330.060 Why?
Drug Approval120128140.060 Why?
Antigens, Neoplasm2202319930.060 Why?
Echocardiography1201749890.060 Why?
Heart Failure12008116710.060 Why?
Incidence12022213550.060 Why?
Risk1201696100.060 Why?
Neuropilin-112024900.060 Why?
Heart1201744040.060 Why?
Neoplasm Proteins1201636170.050 Why?
Registries2202082250.050 Why?
Pamphlets12023710.050 Why?
Risk Assessment42024239960.050 Why?
Age Factors32017183990.050 Why?
Risk Factors62023742130.050 Why?
Ki-67 Antigen120236290.050 Why?
Gene Expression Profiling1201794200.050 Why?
Review Literature as Topic120233480.050 Why?
Axilla120236240.050 Why?
Animals420241684750.050 Why?
Body Weight1201146180.050 Why?
Prospective Studies32023544230.040 Why?
Genomics1201658210.040 Why?
Stroke Volume3202154960.040 Why?
Evidence-Based Medicine1201236880.040 Why?
Telephone120236270.040 Why?
Prevalence12016157330.040 Why?
Administration, Intravaginal120191500.040 Why?
Taxoids120226680.040 Why?
Sentinel Lymph Node Biopsy120237320.040 Why?
Aromatase Inhibitors120225130.040 Why?
Sex Factors12011105540.040 Why?
High-Throughput Nucleotide Sequencing2202136390.040 Why?
Lymph Node Excision1202312710.040 Why?
Ubiquitin Thiolesterase120204550.040 Why?
Logistic Models12011132550.030 Why?
Quality of Life22022133670.030 Why?
Neoplastic Stem Cells1202413510.030 Why?
Receptors, Androgen1202210790.030 Why?
United States32020723400.030 Why?
Diarrhea1202213180.030 Why?
Ligands1202232720.030 Why?
Early Diagnosis1202011860.030 Why?
Tumor Burden1202118920.030 Why?
Predictive Value of Tests22021152660.030 Why?
Atrophy1201916330.030 Why?
Body Mass Index12011129530.030 Why?
Gynecology120195260.030 Why?
Sensitivity and Specificity12008146650.030 Why?
Cardiovascular Diseases12019155020.030 Why?
Adolescent22020883260.030 Why?
Radiotherapy1201914980.020 Why?
Health Care Surveys1201924260.020 Why?
Qualitative Research1202230250.020 Why?
DNA Damage1202024490.020 Why?
Tumor Suppressor Proteins1202028050.020 Why?
Male320193608460.020 Why?
Caregivers1202222380.020 Why?
DNA Mutational Analysis1201841110.020 Why?
Doxorubicin1201622240.020 Why?
Mutation, Missense1201825710.020 Why?
Survival Analysis12021100900.020 Why?
Immunotherapy1202446520.020 Why?
Cell Line, Tumor12024169900.020 Why?
Randomized Controlled Trials as Topic12024102120.020 Why?
Kaplan-Meier Estimate1201764840.020 Why?
Health Status Disparities1201818530.020 Why?
Medication Adherence1201721760.020 Why?
Odds Ratio1201796470.010 Why?
Databases, Factual1202079680.010 Why?
Recurrence1201784660.010 Why?
Health Knowledge, Attitudes, Practice1201940160.010 Why?
Physicians1201945910.010 Why?
Follow-Up Studies12021391060.010 Why?
Cross-Sectional Studies12019261290.010 Why?
Mice12024815390.010 Why?
Cohort Studies12018414950.010 Why?
Lynce's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (191)
Explore
_
Co-Authors (57)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.